Letters
Table. Outcomes in Patients With Ischemic Strokes Receiving Thrombolysis Comparing Stroke Emergency Mobile (STEMO) Groups With Control Weeks STEMO Weeks STEMO Deployment (n = 866) Delivery to hospitals with stroke unit (patients with cardiovascular disease), No. (%)
818 (94.5)
591 (90.9)
Ischemic stroke, No. (%)
614 (70.9)
456 (70.2)
Tissue plasminogen activator treatment, No. (%)
200 (32.6)
110 (24.1)
(n = 192)
(n = 107)
Time, mean (median) [IQR], min
.008
Control Weeks (n = 1460) 1274 (87.3)
P Valueb .02
1041 (71.3) .003
220 (21.1)
.20
(n = 219)
49.9 (22) [9-70]
44.1 (25) [8-68]
.59
43.2 (23) [9-61]
.96
Alarm to imaging
37.7 (35) [30-42]
55.3 (54) [44-65]
Table. Outcomes in Patients With Ischemic Strokes Receiving Thrombolysis Comparing Stroke Emergency Mobile (STEMO) Groups With Control Weeks STEMO Weeks STEMO Deployment (n = 866) Delivery to hospitals with stroke unit (patients with cardiovascular disease), No. (%)
818 (94.5)
591 (90.9)
Ischemic stroke, No. (%)
614 (70.9)
456 (70.2)
Tissue plasminogen activator treatment, No. (%)
200 (32.6)
110 (24.1)
(n = 192)
(n = 107)
Time, mean (median) [IQR], min
.008
Control Weeks (n = 1460) 1274 (87.3)
P Valueb .02
1041 (71.3) .003
220 (21.1)
.20
(n = 219)
49.9 (22) [9-70]
44.1 (25) [8-68]
.59
43.2 (23) [9-61]
.96
Alarm to imaging
37.7 (35) [30-42]
55.3 (54) [44-65]
